Nox2-Induced production of mitochondrial Superoxide in Angiotensin ii-mediated endothelial oxidative stress and hypertension

Antioxidants and Redox Signaling

Volumn 20, Issue 2, 2014, Pages 281-294

  Dikalov, Sergey I ^a   Nazarewicz, Rafal R ^a   Bikineyeva, Alfiya ^a   Hilenski, Lula ^b   Lassègue, Bernard ^b   Griendling, Kathy K ^b   Harrison, David G ^a   Dikalova, Anna E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; DIAZOXIDE; EAVSLKPT; MALIC ACID; MALONIC ACID; MITOEBSELEN; PKC E PEPTIDE ANATAGONIST; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ROTENONE; SMALL INTERFERING RNA; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOPLASM; ELECTRON TRANSPORT; ENDOTHELIUM CELL; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HYPERTENSION; MOUSE; NONHUMAN; ONCOGENE SRC; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; CYCLIC N-OXIDES; CYTOPLASM; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT; ENDOTHELIAL CELLS; GENE SILENCING; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION; MALATES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MITOCHONDRIA, HEART; NADPH OXIDASE; OXIDATIVE STRESS; PROTEIN ISOFORMS; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; SRC-FAMILY KINASES; SUPEROXIDES;

EID: 84891758878     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4918     Document Type: Article

References (54)

1. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233, 2004.
2. Ago T, Kuroda J, Pain J, Fu C, Li H, and Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 106: 1253-1264, 2010.
3. Andrukhiv A, Costa AD, West IC, and Garlid KD. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol 291: H2067-H2074, 2006.
4. Beckman JS, Minor RL, Jr., White CW, Repine JE, Rosen GM, and Freeman BA. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem 263: 6884-6892, 1988.
5. Bendall JK, Rinze R, Adlam D, Tatham AL, de Bono J, Wilson N, Volpi E, and Channon KM. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res 100: 1016-1025, 2007.
6. Block K, Eid A, Griendling KK, Lee DY, Wittrant Y, and Gorin Y. Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 283: 24061-24076, 2008.
7. Block K, Gorin Y, and Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A 106: 14385-14390, 2009.
8. Boulden BM, Widder JD, Allen JC, Smith DA, Al-Baldawi RN, Harrison DG, Dikalov SI, Jo H, and Dudley SC, Jr. Early determinants of H2O2-induced endothelial dysfunction. Free Radic Biol Med 41: 810-817, 2006.
9. Case AJ, Li S, Basu U, Tian J, and Zimmerman MC. Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons. Am J Physiol Heart Circ Physiol 305: H19-H28, 2013.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., JonesDW,Materson BJ,Oparil S,Wright JT, Jr., and Roccella EJ. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42: 1206-1252, 2003.
11. Costa AD and Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol 295: H874-H882, 2008.
12. Csiszar A, Labinskyy N, Zhao X, Hu F, Serpillon S, Huang Z, Ballabh P, Levy RJ, Hintze TH, Wolin MS, Austad SN, Podlutsky A, and Ungvari Z. Vascular superoxide and hydrogen peroxide production and oxidative stress resistance in two closely related rodent species with disparate longevity. Aging Cell 6: 783-797, 2007.
13. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 51: 1289-1301, 2011.
14. Dikalov S, Griendling KK, and Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 49: 717-727, 2007.
15. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, and Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 45: 1340-1351, 2008.
16. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, and Griendling KK. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112: 2668-2676, 2005.
17. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, and Dikalov SI. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116, 2010.
18. Dikalova AE, Gongora MC, Harrison DG, Lambeth JD, Dikalov S, and Griendling KK. Upregulation of Nox1 in vascular smooth muscle leads to impaired endotheliumdependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 299: H673-H679, 2010.
19. Doughan AK and Dikalov SI. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid Redox Signal 9: 1825-1836, 2007.
20. Doughan AK, Harrison DG, and Dikalov SI. Molecular Mechanisms of angiotensin II-mediated mitochondrial dysfunction. linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102: 488-496, 2008.
21. Koziel R, Pircher H, Kratochwil M, Lener B, Hermann M, Dencher NA, Jansen-Durr P. Mitochondrial respiratory chain complex I is inactivated by NADPH oxidase Nox4. Biochem J 452: 231-239, 2013.
22. Fujii A, Nakano D, Katsuragi M, Ohkita M, Takaoka M, Ohno Y, and Matsumura Y. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Eur J Pharmacol 552: 131-134, 2006.
23. Garlid KD, Paucek P, Yarov-Yarovoy V, Sun X, and Schindler PA. The mitochondrial KATP channel as a receptor for potassium channel openers. J Biol Chem 271: 8796-8799, 1996.
24. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
25. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
26. Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, Hoch N, Dikalov S, Rudzinski P, Kapelak B, Sadowski J, and Harrison DG. Calcium-dependent NOX5 NADPH oxidase contributes to vascular oxidative stress in human coronar artery disease. J Am Coll Cardiol 52: 1803-1809, 2008.
27. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004.
28. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C, and Harrison DG. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 296: R208-R216, 2009.
29. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, and Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 45: 438-444, 2005.
30. Kolosova NG, Akulov AE, Stefanova NA, Moshkin MP, Savelov AA, Koptyug IV, Panov AV, and Vavilin VA. Effect of malate on the development of rotenone-induced brain changes in Wistar and OXYS rats: an MRI study. Dokl Biol Sci 437: 72-75, 2011.
31. Krege JH, Hodgin JB, Hagaman JR, and Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25: 1111-1115, 1995.
32. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, and Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A 107: 15565-15570, 2010.
33. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
34. Lassegue B and Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 30: 653-661, 2010.
35. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redoxsensitive signaling pathways. Circ Res 88: 888-894, 2001.
36. Lavoie JL and Sigmund CD. Minireview: overview of the renin-Angiotensin system-An endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003.
37. Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, and Gutterman DD. Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 93: 573-580, 2003.
38. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, and Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105: 249-259, 2009.
39. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18: 69-82, 2006.
40. Page TH, Smolinska M, Gillespie J, Urbaniak AM, and Foxwell BM. Tyrosine kinases and inflammatory signalling. Curr Mol Med 9: 69-85, 2009.
41. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, and Greenamyre JT. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280: 42026-42035, 2005.
42. Panov A, Schonfeld P, Dikalov S, Hemendinger R, Bonkovsky HL, and Brooks BR. The neuromediator glutamate, through specific substrate interactions, enhances mitochondrial ATP production and reactive oxygen species generation in nonsynaptic brain mitochondria. J Biol Chem 284: 14448-14456, 2009.
43. Queliconi BB, Wojtovich AP, Nadtochiy SM, Kowaltowski AJ, and Brookes PS. Redox regulation of the mitochondrial K(ATP) channel in cardioprotection. Biochim Biophys Acta 1813: 1309-1315, 2011.
44. Selivanov VA, Votyakova TV, Pivtoraiko VN, Zeak J, Sukhomlin T, Trucco M, Roca J, and Cascante M. Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol 7: e1001115, 2011.
45. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
46. Smith RA, Hartley RC, and Murphy MP. Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal 15: 3021-3038, 2011.
47. Takac I, Schroder K, Zhang L, Lardy B, Anilkumar N, Lambeth JD, Shah AM, Morel F, and Brandes RP. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem 286: 13304-13313, 2011.
48. Trounce IA, Kim YL, Jun AS, and Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264: 484-509, 1996.
49. Tsygankov AY and Shore SK. Src: regulation, role in human carcinogenesis and pharmacological inhibitors. Curr Pharm Des 10: 1745-1756, 2004.
50. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, and Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001.
51. Widder JD, Guzik TJ, Mueller CF, Clempus RE, Schmidt HH, Dikalov SI, Griendling KK, Jones DP, and Harrison DG. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler Thromb Vasc Biol 27: 762-768, 2007.
52. Xi Q, Cheranov SY, and Jaggar JH. Mitochondria-derived reactive oxygen species dilate cerebral arteries by activating Ca2 + sparks. Circ Res 97: 354-362, 2005.
53. Zhang A, Jia Z, Wang N, Tidwell TJ, and Yang T. Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int 80: 51-60, 2011.
54. Zhang DX and Gutterman DD. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 292: H2023-H2031, 2007.